Catalyst Wire Dossier Catalyst Wire Dossier

POS

· Ocuphire Pharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for POS, covering 2026-03-12 to 2026-08-17. Get the full timeline:

Most recent: Clinical Trial Results: Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia [Phase 3]

See pricing